BioSpace News Archive

United Therapeutics Corporation announced that it will report its first quarter 2023 financial results before the market opens on Wednesday, May 3, 2023.

Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the first quarter ended April 1, 2023.

Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the first quarter ending March 31, 2023.

Vektor Medical today announced former Philips and Biotronik medical technology leader Marlou Janssen and Yale Clinical Professor of Medicine and past American College of Cardiology (ACC) Connecticut Chapter Governor and President Dr. Craig McPherson have joined Vektor’s advisory board.

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced participation in the following investor and scientific conferences in May.

Oxford Biomedica plc (LSE:OXB) today announces the appointment of Ms Leone Patterson as an Independent Non-Executive Director.

Oculis Holding AG today announced the opening of its Boston, Massachusetts office, expanding its US presence in preparation of becoming an active player in the US market and demonstrating execution of its strategy. This includes the hiring of Dr. Fang Li as the new US-based Senior Vice President, Regulatory Affairs.

PolyPid Ltd. today announced that it will report its first quarter 2023 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, May 10, 2023.

EyePoint Pharmaceuticals, Inc. today announced it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, May 3, 2023 to report its first quarter 2023 financial results and highlight recent corporate developments.

CytoSorbents Corporation will report first quarter 2023 operating and financial results after the market close on Tuesday, May 2, 2023.